Search JIM Advanced Search

Journal of Integrative Medicine

    Next Articles

Antidepressant mechanism of Xiaoyaosan: A perspective from energy metabolism of the brain and intestine

Meng-ting Xiaoa,b,c, Sen-yan Wanga,b,c, Xiao-ling Wua,b,c, Zi-yu Zhaoa,b,c, Hui-min Wanga,b,c, Hui-min Liua,b,c, Xue-mei Qina,b,c, Xiao-jie Liua,b,c   

  1. a. Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, Shanxi Province, China
    b. Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan 030006, Shanxi Province, China
    c. Institute of Biomedicine and Health, Shanxi University, Taiyuan 030006, Shanxi Province, China
  • Received:2024-11-05 Accepted:2025-06-12 Published:2025-08-15
  • Contact: Xiao-jie Liu; Xue-mei Qin E-mail:liuxiaojie@sxu.edu.cn; qinxm@sxu.edu.cn

Objective

This study investigated the antidepression mechanisms of Xiaoyaosan (XYS), a classic Chinese prescription, from the perspective of energy metabolism in the brain and intestinal tissues.

Methods

Chronic unpredictable mild stress model—a classic depression rat model—was established. Effects of XYS on behaviors and gastrointestinal motility of depressed rats were investigated. Effects of XYS on energetic charge (EC), adenosine triphosphate-related enzymes, and key enzymes of energy metabolism in both hippocampus and jejunum tissues of depressed rats were investigated using high-performance liquid chromatography, biochemical analysis, and real-time quantitative polymerase chain reaction, respectively. Spearman correlation analysis was conducted to construct a correlation network of “behavior-brain energy metabolism-intestinal energy metabolism” of depression.

Results

XYS significantly reduced the abnormal behaviors observed in depressed rats and increased the EC and the activity of Na+-K+-ATPase and Ca2+-Mg2+-ATPase in hippocampus and jejunum tissues of depressed rats. XYS restored the key energetic pathways that had been interrupted by depression, including glycolysis, tricarboxylic acid cycle, and oxidative phosphorylation. Furthermore, XYS exhibited antidepressive effects in terms of regulating energy metabolism in tissues of the brain and intestine.

Conclusion

XYS significantly corrected the disturbances in EC and energy metabolism-related enzymes of both brain and intestinal tissues, alleviating both core and concomitant symptoms of depression. The current findings underscore the role of energy metabolism in the antidepressive activity of XYS, providing a fresh perspective on depression, and novel research strategies for revealing the mechanism of actions of traditional Chinese medicines on multi-site and multi-symptom diseases.

Key words: Xiaoyaosan, Depression, Concomitant symptoms, Traditional Chinese medicine, Brain energy metabolism, Intestinal energy metabolism

[1] Ya-ting Ai, Shi Zhou, Ming Wang, Tao-yun Zheng, Hui Hu, Yun-cui Wang, Yu-can Li, Xiao-tong Wang, Peng-jun Zhou. Development of a machine learning-based risk prediction model for mild cognitive impairment with spleen-kidney deficiency syndrome in the elderly. Journal of Integrative Medicine, 2025, 23(4): 390-397.
[2] Xuan Yin, Xiao-ling Zeng, Jing-jing Lin, Wen-qing Xu, Kai-yu Cui, Xiu-tian Guo, Wei Li, Shi-fen Xu. Brain functional changes following electroacupuncture in a mouse model of comorbid pain and depression: a resting-state functional magnetic resonance imaging study. Journal of Integrative Medicine, 2025, 23(2): 159-168.
[3] Shi-yun Yan. Thoughts on the construction of flagship hospitals of integrated traditional Chinese and Western medicine in China. Journal of Integrative Medicine, 2025, 23(1): 12-14.
[4] Yuan He, Xiao-xuan Qin, Ming-wei Liu, Wei Sun. Morin, a matrix metalloproteinase 9 inhibitor, attenuates endothelial-to-mesenchymal transition in atherosclerosis by downregulating Notch-1 signaling. Journal of Integrative Medicine, 2024, 22(6): 683-695.
[5] Ming Huang, Yao-yuan Liu, Ke Xiong, Feng-wen Yang, Xin-yao Jin, Zhao-qi Wang, Jun-hua Zhang, Bo-li Zhang. The role and advantage of traditional Chinese medicine in the prevention and treatment of COVID-19. Journal of Integrative Medicine, 2023, 21(5): 407-412.
[6] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[7] Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231.
[8] Si-chun Gu, Jie Zhou, Qing Ye, Can-xing Yuan. Pingchan granule for depressive symptoms in Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(2): 120-128.
[9] Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!